Dycine Pharmaceuticals Limited, a active public limited company, was established on 30 July 2010 in Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74992UP2010PLC041545. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹26.48 Cr.
It upholds a compliant status. Employing 248 professional, Its leadership includes Rupesh Kumar Gupta (Director), Alok Kumar Singh (Director), Sai Uttam Bahirat Patil (Director). Past directors included Alok Kumar Singh, Sai Uttam Bahirat Patil, Abhishek Agrawal. It holds ₹30.71 Cr open charges and ₹9.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 381 Block Iii Ganga Shopping Complex, Sector 29, Noida, Uttar Pradesh, 201302.
U74992UP2010PLC041545
041545
30 July 2010
₹30.00 Cr
₹26.48 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Dycine Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupesh Kumar Gupta | Director | 30 Jul 2010 | Current |
| Alok Kumar Singh | Director | 30 Jul 2010 | Current |
| Sai Uttam Bahirat Patil | Director | 25 Sep 2024 | Current |
| Piyush Kumar Singh | Director | 30 Jul 2010 | Current |
| Abhishek Agrawal | Director | 25 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dycine Pharmaceuticals Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.94% increase. The company also saw a substantial fall in profitability, with a 38.54% decrease in profit. The company's net worth Soared by an impressive increase of 83.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Dycine Pharmaceuticals had a promoter holding of 83.71% and a public holding of 16.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹307,122,198.00
₹95,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Hdfc Bank Limited | ₹29.37 Cr | Open |
| 28 Dec 2021 | Hdfc Bank Limited | ₹5.94 M | Open |
| 02 Nov 2018 | Others | ₹2.88 M | Open |
| 04 Jan 2018 | Hdfc Bank Limited | ₹1.25 M | Open |
| 08 Jun 2017 | Hdfc Bank Limited | ₹3.30 M | Open |
Explore comprehensive loan charge details -
Dycine Pharmaceuticals has a workforce of 248 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dycine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dycine Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Piyush Kumar Singh was appointed as a Cfo was appointed as a Cfo on 28 Apr 2025 & has been associated with this company since 7 months 6 days . was completed.
Progress on Dycine Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Sai Uttam Bahirat Patil was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Progress on Abhishek Agrawal was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 29.37 Cr registered on 28 Jan 2022 with Charge ID 100559499 was modified on 02 Sep 2024. was documented.
Garima Malik was appointed as a Company Secretary was appointed as a Company Secretary on 31 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The CIN of Dycine Pharmaceuticals Limited is U74992UP2010PLC041545.
Dycine Pharmaceuticals Limited is headquartered at Shop No. 381 Block Iii Ganga Shopping Complex, Sector 29, Noida, Uttar Pradesh, 201302.
Dycine Pharmaceuticals Limited was incorporated on 30 July 2010.
The current directors of Dycine Pharmaceuticals Limited are
The primary industry of Dycine Pharmaceuticals Limited is Trade.
Dycine Pharmaceuticals Limited is unlisted.
The authorized capital of Dycine Pharmaceuticals Limited is ₹30.00 Cr, and the paid-up capital is ₹26.48 Cr.
The compliance status of Dycine Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX